Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | tubulin epsilon chain, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | alpha tubulin, putative | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | tubulin gamma chain | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | beta tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | gamma-tubulin | 0.0029 | 0 | 0.5 |
Giardia lamblia | Alpha-tubulin | 0.0029 | 0 | 0.5 |
Plasmodium vivax | tubulin alpha chain, putative | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | tubulin beta-4 chain | 0.0029 | 0 | 0.5 |
Plasmodium vivax | tubulin alpha chain, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | tubulin beta-1 chain | 0.0029 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 1 | 1 |
Trypanosoma brucei | alpha tubulin | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | tubulin epsilon chain, putative | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | epsilon tubulin | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | tubulin alpha-2 chain | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | epsilon tubulin, putative | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0029 | 0 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0 | 0.5 |
Plasmodium vivax | tubulin gamma chain, putative | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | tubulin beta chain | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | epsilon tubulin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0029 | 0 | 0.5 |
Giardia lamblia | Beta tubulin | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 1 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 1 | 1 |
Loa Loa (eye worm) | BEN-1 protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin alpha-1 chain, putative | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | tubulin beta-2A chain | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | alpha-tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | beta tubulin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | alpha tubulin 2 | 0.0029 | 0 | 0.5 |
Plasmodium vivax | tubulin beta chain, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | beta-1 tubulin, putative | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | alpha-tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | epsilon tubulin | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | beta-tubulin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | tubulin/FtsZ family, GTPase domain-containing protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | tubulin gamma chain | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | beta-tubulin | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | alpha tubulin TUBA1 | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | tubulin gamma chain | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Giardia lamblia | Alpha-tubulin | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | epsilon tubulin | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | alpha tubulin 1 | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.0029 | 0 | 0.5 |
Giardia lamblia | Gamma tubulin | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | tubulin beta chain | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | tubulin alpha chain | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | tubulin gamma chain | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 1 | 1 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0029 | 0 | 0.5 |
Leishmania major | epsilon tubulin, putative | 0.0029 | 0 | 0.5 |
Leishmania major | alpha tubulin | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | BEN-1 protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 1 | 1 |
Trypanosoma brucei | beta tubulin | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.0029 | 0 | 0.5 |
Leishmania major | beta tubulin | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | alpha-tubulin I, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 1 | 1 |
Trypanosoma brucei | beta tubulin | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | tubulin alpha chain | 0.0029 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 12.9953 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (binding) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.